In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies
Abstract Parkinson’s disease (PD) is characterized by the accumulation of alpha-synuclein (aSyn) aggregates in specific brain regions, which are likely to be the disease-causing entities. Herein, we employed novel, systemically administered, brain-penetrating viral vectors (PHP.eB AAVs) in order to...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-09-01
|
| Серии: | Acta Neuropathologica Communications |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40478-025-02121-w |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
